Drug intelligence / Profile preview

MB-JEV

Development stage
Discontinued
Lead developer
The Chemo-Sero-Therapeutic Research Institute
Modality
Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

MB-JEV is an inactivated Japanese encephalitis (JE) vaccine derived from mouse brain tissue. It contains inactivated whole virus (typically Nakayama or Beijing-1 strain) and is used to induce immunity against the Japanese encephalitis virus. The vaccine works by stimulating the immune system to produce neutralizing antibodies that protect against infection with the JE virus. Historically, it was widely used for both travelers and residents in endemic areas, especially children. However, due to concerns about rare but serious adverse events and advances in manufacturing technology, production of MB-JEV has ceased or been restricted in many countries; newer cell culture-derived vaccines have largely replaced it[1][2][3][5]. The primary indication for MB-JEV was prevention of Japanese encephalitis.

Brand names
MB-JEV
Other names
mouse brain-derived Japanese encephalitis vaccineJE-MBBiken vaccine
02

Targets

E (Tick-borne encephalitis virus envelope protein)

Beyond the preview

Go deeper on MB-JEV.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MB-JEV.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call